Innovative HIV Treatment Becomes Accessible All over the World
1231  

Innovative HIV Treatment Becomes Accessible All over the World

The World Heath Organization and UNAIDS have announced approval of a revolutionary pricing agreement that will facilitate access to the first affordable and all-purpose single-pill HIV regimen including Dolutegravir (DTG) for the public sector in low and middle-income countries. Its price will be around 75 ...

October 02, 2017
ECUO  News  
New high-quality antiretroviral therapy to be launched in South Africa, Kenya and over 90 low-and middle-income countries at reduced price
1321  

New high-quality antiretroviral therapy to be launched in South Africa, Kenya and over 90 low-and middle-income countries at reduced price

A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and middle-income countries (LMICs) at around US$75 per person, per year. The agreement is expected to ...

September 26, 2017
News  
Championing access to HIV services for key populations in Africa
1056  

Championing access to HIV services for key populations in Africa

The AIDS response in Africa has come a long way and the continent is seeing results in many areas, including the dramatic reduction in the number of babies being born with HIV and an equally dramatic increase in access to HIV treatment. Nevertheless, inequalities in ...

April 05, 2017
News  
European Parliament calls for new rules to improve access to medicines
1087  

European Parliament calls for new rules to improve access to medicines

After several years of lobbying work and pressure from patient organisations, the European Parliament has now published a report on the EU’s options for improving access to medicines. This useful snapshot from the European Public Health Alliance describes the report. The report is non-binding though ...

March 03, 2017
EATG  News  

HIV activist battles drugs and discrimination in Ukraine

Growing up in eastern Ukraine, Svitlana Moroz said she was a typically reckless teenager who believed she’d live forever. She shared needles with friends to inject opium, had unprotected sex with a guy her own age, and five months after hooking up with him, learned she ...

February 13, 2017
EATG  News  

WHO calls for list of essential diagnostics

Last June, a Perspective piece in the New England Journal of Medicine noted the critical place that the World Health Organization’s list of Essential Medicines had assumed in global health policy and responses — donors, governments and insurers were all more likely to invest in ...

February 13, 2017
EATG  News  

EMA grants accelerated assessment, validates Marketing Authorization Application for AbbVie’s investigational hepatitis C therapy

European Medicines Agency grants accelerated assessment, validates Marketing Authorization Application for AbbVie’s investigational regimen of glecaprevir/pibrentasvir (G/P) for the treatment of chronic hepatitis C in all major genotypes (GT1-6) – If approved, G/P may provide a shorter, eight week, once-daily, ribavirin-free treatment option for the majority ...

January 25, 2017
EATG  News  

The war on drugs causes massive human rights violations

Experts discuss the devastating effects of prohibition and their reasons for reform The war on drugs has had devastating effects on human rights and public health worldwide, argue experts in The BMJ. In November, the journal argued that prohibition laws have failed and called on doctors to ...

January 24, 2017
EATG  News  

Non-adherence most important risk factor for sofosbuvir/ledipasvir failure

Research carried out by Mount Sinai Medical Center, New York, found that non-adherence was the strongest risk factor for treatment failure in people taking sofosbuvir/ledipasvir (Harvoni). The main reasons cited for non-adherence were failing to take medication as prescribed and hospitalisation. The findings were presented at ...

November 25, 2016
EATG  EATG  News